840487C

18:3 PG

1,2-dilinolenoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt), chloroform

• Sinónimos: 1,2-di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phospho-(1′racglycerol) (sodium salt); PG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))
• Fórmula empírica (notación de Hill): C₄₂H₇₀O₁₀PNa
• Número de CAS: 474943-20-9
• Peso molecular: 788.96
• UNSPSC Code: 51191904
• NACRES: NA.25

Propiedades

• assay: >99% (TLC)
• form: liquid
• packaging: pkg of 1 × 2.5 mL (840487C-25mg)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 840487C
• concentration: 10 mg/mL (840487C-25mg)
• lipid type: phospholipids
• shipped in: dry ice
• storage temp.: −20°C
• InChI: 1S/C42H71O10P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-41(45)49-37-40(38-51-53(47,48)50-36-39(44)35-43)52-42(46)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h5-8,11-14,17-20,39-40,43-44H,3-4,9-10,15-16,21-38H2,1-2H3,(H,47,48);/q;+1/p-1/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-;/t39?,40-;/m1./s1
• InChI key: JIBYBHPPGFSINU-NYUFXKKKSA-M

Descripción

General description

18:3 PG or 1,2-dilinolenoyl-sn-glycero-3-phospho-(1′-rac-glycerol) is a sodium salt of glycerophospholipid with substitution of two linolenic acids at sn-1 and sn-2 positions and phospho-(1′-rac-glycerol) at the sn-3 position of the glycerol backbone.

Packaging

5 mL Clear Glass Sealed Ampule (840487C-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Información de seguridad

• pictograms: GHS06,GHS08
• signalword: Danger
• hcodes: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• pcodes: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• target_organs: Central nervous system, Liver,Kidney
• wgk_germany: WGK 3